Pill Identifier App

Vumon Side Effects

Generic Name: teniposide

Note: This page contains side effects data for the generic drug teniposide. It is possible that some of the dosage forms included below may not apply to the brand name Vumon.

It is possible that some side effects of Vumon may not have been reported. These can be reported to the FDA here. Always consult a healthcare professional for medical advice.

For the Consumer

Applies to teniposide: intravenous solution

As well as its needed effects, teniposide (the active ingredient contained in Vumon) may cause unwanted side effects that require medical attention.

If any of the following side effects occur while taking teniposide, check with your doctor immediately:

More common
  • Black, tarry stools
  • blood in urine or stools
  • chills
  • cough or hoarseness
  • fever
  • hives
  • lower back or side pain
  • painful or difficult urination
  • pinpoint red spots on skin
  • shortness of breath
  • tightness in chest or wheezing
  • troubled breathing
  • unusual bleeding or bruising

If any of the following side effects occur while taking teniposide, check with your doctor or nurse as soon as possible:

More common
  • Flushing of face
  • sores in mouth or on lips
  • unusually fast heartbeat
  • unusual tiredness
Less common
  • Skin rash
Rare
  • Decreased urination
  • swelling of face, fingers, feet, or lower legs
  • yellow eyes or skin

Some teniposide side effects may not need any medical attention. As your body gets used to the medicine these side effects may disappear. Your health care professional may be able to help you prevent or reduce these side effects, but do check with them if any of the following side effects continue, or if you are concerned about them:

More common
  • Diarrhea
  • nausea and vomiting

This medicine often causes a temporary loss of hair. After treatment with teniposide has ended, normal hair growth should return.

For Healthcare Professionals

Applies to teniposide: intravenous solution

Hematologic

Hematologic side effects have included bone marrow suppression which is the most significant toxicity associated with teniposide (the active ingredient contained in Vumon) therapy. Hematologic effects including neutropenia (less than 2,000 ANC/mcL), leukopenia (less than 3,000 WBC/mcL), anemia (88%), thrombocytopenia (less than 100,000 platelets/mcL) (85%), myelosuppression (unspecified) (75%), and bleeding (5%) have been reported. Sepsis, sometimes fatal, may be a consequence of severe myelosuppression.

Hypersensitivity

Hypersensitivity side effects (5%) have been reported. These have included some potentially life threatening hypersensitivity reactions with anaphylaxis-like symptoms.

The hypersensitivity reaction may include chills, fever, urticaria, tachycardia, bronchospasm, dyspnea, hypertension or hypotension, and facial flushing. Treatment for a severe hypersensitivity reaction include prompt use of antihistamines, corticosteroids, epinephrine, intravenous fluids, and other supportive measures.

One analysis of hypersensitivity reactions to teniposide concluded that the frequency of the reactions is substantially higher in patients with neuroblastoma and brain tumors.

Cardiovascular

Cardiovascular side effects including hypotension/cardiovascular (2%) have been reported. One episode of sudden death attributable to probable arrhythmia and intractable hypotension has also been reported.

Oncologic

Oncologic side effects include one report of a relative risk of developing secondary acute nonlymphocytic leukemia approximately twelve times that of patients treated with less intensive schedules.

The patients in the report were children with acute lymphoblastic leukemia in remission who received teniposide plus other chemotherapeutic agents at weekly or twice weekly doses.

Compounds with similar mechanisms of action and mutagenicity profiles have been carcinogenic. Teniposide should be considered to be a potential carcinogen. Teniposide has been shown to be mutagenic in various bacterial and mammalian genetic toxicity tests.

Gastrointestinal

Gastrointestinal side effects including mucositis (76%), diarrhea (33%), and nausea/vomiting (29%) have been reported.

Immunologic

Immunologic side effects including infection (12%) have been reported.

Dermatologic

Alopecia, which sometimes progressed to total baldness, was usually reversible.

Dermatologic side effects including alopecia (9%) and rash (3%) have been reported.

General

General side effects including fever and asthenia have been reported.

Nervous system

Nervous system side effects have included headache, confusion, neurotoxicity and, at investigational high doses, acute CNS depression has been reported.

Other

Other side effects have included three case reports of somnolence, hypotension, and metabolic acidosis which have been reported with teniposide (the active ingredient contained in Vumon) doses at three to five times the standard dose.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate safety, effectiveness, or appropriateness for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of materials provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the substances you are taking, check with your doctor, nurse, or pharmacist.

Hide
(web4)